New cancer drug enters first human trials
Disease control
Terminated
This was the first human study testing an experimental drug called DS-9606a in people with advanced solid tumors, including ovarian, lung, and pancreatic cancers. The main goals were to find a safe dose and understand how the body processes the drug. The study was terminated earl…
Phase: PHASE1 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC